| SKU | ISG002872 |
| Brand | Forflozin |
| Categories | Medication & Treatments |
| Color | black |
| Shop by Concerns | High Blood Sugar |
| Gender | Unisex |
| Shop By Goals | Blood Glucose Control |
| Imported Or Local | Local |
| Ingredient | Dapagliflozin |
| UPC | 6223004042102 |
| Specialty | Once Daily Oral Antidiabetic SGLT2 Inhibitor |
| Sub Categories | Insulin And Diabetic Medicines |
| Warning | Keep Out of Reach of Children Not for type 1 diabetes Prescription only Use With Caution In Renal Impairment Risk of genital and urinary infections Risk of Ketoacidosis |
Forflozin 10
Description:
Forflozin 10 mg film-coated tablets is an oral antidiabetic prescription medicine containing dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is used as part of comprehensive type 2 diabetes mellitus management to help lower blood glucose levels, improve glycemic control, and support long-term diabetes care. By blocking SGLT2 in the kidneys, Forflozin 10 promotes urinary glucose excretion, helping reduce elevated blood sugar and contributing to additional benefits such as modest weight reduction and blood pressure improvement when used appropriately under medical supervision.
Indications:
- Type 2 diabetes mellitus in adults to improve glycemic control as monotherapy when diet and exercise alone do not provide adequate control and when metformin is not suitable (e.g., intolerance or contraindication).
- Type 2 diabetes mellitus in adults as add-on therapy in combination with other antidiabetic medications (such as metformin, sulfonylureas, insulin, or DPP-4 inhibitors) when these agents, together with diet and exercise, do not achieve adequate blood glucose control.
- Helps reduce fasting and postprandial (after-meal) blood glucose levels and HbA1c in patients with type 2 diabetes.
- May support modest weight reduction and blood pressure lowering as part of overall metabolic control in type 2 diabetes (when used as prescribed).
- Not indicated for type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Active Ingredients / Key Components:
- Dapagliflozin – 10 mg per film-coated tablet.
- Excipients: The full list of inactive ingredients (tablet core and coating components such as fillers, binders, colorants, and stabilizers) is not available in the provided information. Please refer to the official package leaflet for a complete excipient list.
Dosage & Administration / How to Use:
- Recommended adult dose: 10 mg dapagliflozin (one Forflozin 10 tablet) once daily, or as directed by your physician.
- Administration: Swallow the tablet whole with a glass of water. It can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
- Combination therapy: When used with other antidiabetic medicines (such as insulin or sulfonylureas), your doctor may adjust the dose of the accompanying medication to reduce the risk of hypoglycemia.
- Renal and hepatic impairment: Dose adjustment, initiation, or discontinuation may be required in patients with reduced kidney function or liver disease. Use only under close medical supervision in these conditions.
- Missed dose: If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to make up for a missed tablet.
- Duration of use: Long-term treatment as prescribed by your doctor, along with diet, exercise, and regular blood glucose monitoring.
- Hydration: Maintain adequate fluid intake during treatment, especially in hot weather, in elderly patients, or in those taking diuretics, to reduce the risk of dehydration.
- Always follow your healthcare provider’s instructions and the directions on the product label. Do not change your dose or stop the medicine without consulting your doctor.
Clinical Benefits:
- Helps significantly lower blood glucose levels in adults with type 2 diabetes by increasing urinary glucose excretion through SGLT2 inhibition in the kidneys.
- Contributes to a reduction in HbA1c, supporting improved long-term glycemic control when used alongside diet and exercise and/or other antidiabetic medications.
- May support weight reduction in many patients due to calorie loss through glucose excretion in the urine.
- Can provide a modest blood pressure–lowering effect in some patients as part of overall cardiometabolic risk management.
- Offers an oral, once-daily treatment option that can be combined with other antidiabetic medications for individualized diabetes therapy.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity to dapagliflozin or any of the excipients.
- Not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis due to an increased risk of ketoacidosis.
- Use with caution in patients with moderate to severe renal impairment, end-stage renal disease, or those on dialysis. Efficacy is reduced and risks may be increased in these populations.
- Use with caution in patients with hypotension, volume depletion, or those taking diuretics, ACE inhibitors, or ARBs, as dapagliflozin may increase the risk of low blood pressure and dehydration.
- Increased risk of genital and urinary tract infections (including fungal infections) due to glycosuria; patients should maintain good personal hygiene and seek medical advice if symptoms occur.
- Cases of ketoacidosis (including euglycemic ketoacidosis) have been reported with SGLT2 inhibitors. Seek immediate medical attention if symptoms such as nausea, vomiting, abdominal pain, excessive thirst, difficulty breathing, confusion, or unusual fatigue occur.
- Monitor kidney function periodically, especially in elderly patients and those with pre-existing renal impairment.
- Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding. Use during pregnancy and lactation is generally not recommended unless clearly needed and prescribed by a physician.
- Use with caution in patients with a history of recurrent urinary tract infections, genital infections, cardiovascular disease, or low blood pressure.
- May increase the risk of hypoglycemia when used in combination with insulin or insulin secretagogues (e.g., sulfonylureas); dose adjustment of the other agents may be necessary.
- Consult your doctor before use if you have liver disease, severe infection, are undergoing major surgery, or have reduced oral intake, as temporary discontinuation may be required.
- Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, cardiovascular disease, or hypotension.
- Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
- Keep out of reach of children.
Side Effects:
- Common side effects: Genital infections (e.g., vulvovaginal candidiasis, balanitis), urinary tract infections, increased urination, thirst, mild dehydration, back pain, and dyslipidemia (slight changes in blood lipids).
- Less common but important side effects: Hypotension (low blood pressure), dizziness, especially in patients on diuretics or with low blood volume; rare cases of acute kidney injury; increased creatinine or decreased eGFR.
- Serious side effects (seek immediate medical attention): Signs of ketoacidosis (nausea, vomiting, abdominal pain, difficulty breathing, confusion, unusual fatigue), severe urinary tract infection (fever, chills, flank pain), severe genital infections, signs of severe dehydration (very dry mouth, extreme thirst, reduced urination, dizziness, fainting), or allergic reactions (rash, itching, swelling of face/lips/tongue, difficulty breathing).
- If you experience any persistent, bothersome, or unusual symptoms while taking Forflozin 10, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the original packaging (exact storage temperature not provided; refer to the product carton or leaflet for detailed storage conditions).
Specifications:
- Product form: Film-coated tablets for oral use.
- Strength: 10 mg dapagliflozin per tablet.
- Pack size: 30 film-coated tablets per pack (30 f.c. tabs.).
- Intended use: Prescription antidiabetic medicine for adults with type 2 diabetes mellitus.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
